StemCell Institute Inc. operates a stem cell banking business in Japan. It also conducts research and development of new cell-based treatments, pharmaceuticals, and medical devices. Additional activities include cell contract management and transportation, extraction, purification, processing, storage, testing, and sales of biological tissue-derived components, as well as medical facility operation and management. Incorporated in 1999 and headquartered in Tokyo, Japan, the company is a subsidiary of Trim Medical Holdings Inc.